GlassScriptPhysician profile
Werner T De Riese
NPI 1861478240
$1,311.50
in general payments reported to CMS, 2019-2025
18 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $21.26 · 2022: $123 · 2023: $95.25 · 2024: $510 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547 · Travel and Lodging: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.74 |
| Travel and Lodging | $256.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $509.92 | 2024 | Aquabeam System |
| Hologic Sales and Service, LLC | $118.90 | 2019 | |
| Therapeuticsmd, INC. | $106.58 | 2019 | |
| Janssen Biotech, INC. | $99.71 | 2022 | |
| Intuitive Surgical, INC. | $95.25 | 2023 | Da Vinci Surgical System |
| Allergan, INC. | $82.23 | 2019 | |
| Astellas Pharma US INC | $65.34 | 2025 | Xtandi |
| Boston Scientific Corporation | $50.00 | 2020-2025 | Spaceoar Vue System - 10ml |
| C. R. Bard, INC. & Subsidiaries | $45.34 | 2025 | |
| Medtronic, INC. | $23.68 | 2022 | |
| Bioprotect Medical, INC. | $22.04 | 2025 | Bioprotect Balloon Implant System |
| Laborie Medical Technologies Corp. | $18.84 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Menarini Silicon Biosystems, INC. | $17.56 | 2025 | |
| Rigel Pharmaceuticals, INC. | $17.53 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $14.72 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $12.67 | 2019 | |
| Cardinal Health 414 LLC | $11.19 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,912,024.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Werner De Riese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.